drugset / Trial / NCT01867762
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the effectiveness and safety of JNJ 49095397 in participants with symptomatic moderate to severe chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2013-09-09
- Primary completion
- 2014-08-06
- Completion
- 2014-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ 49095397 | Small molecule | 400 ug | Inhaled |